Accomplished Marketing Leader Niki Hall Joins Five9 as Chief Marketing Officer
Hall will lead the company’s global marketing strategy, focusing on driving business growth through product differentiation, market visibility and innovative customer... Read more.
Equity Residential Issues 2023 ESG Report
CHICAGO–(BUSINESS WIRE)–Equity Residential (NYSE: EQR), a recognized leader in Environmental, Social and Governance (ESG) principles, today announced... Read more.
Nuveen Closed-End Funds Declare Pre-Merger Distributions
NEW YORK–(BUSINESS WIRE)–Nuveen today announced that three Nuveen Closed-End Funds have declared pre-merger distributions. The specific distribution... Read more.
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
Arcus Biosciences Announces New Employment Inducement Grants
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated... Read more.
Energy Recovery Announces Leadership Transition
Appoints David Moon Interim CEO SAN LEANDRO, Calif.–(BUSINESS WIRE)–Energy Recovery, Inc. (Nasdaq: ERII) today announced Mr. David Moon, a current member... Read more.
Crescent Energy Schedules Third Quarter 2023 Earnings Release and Conference Call
HOUSTON–(BUSINESS WIRE)–Crescent Energy Company (NYSE: CRGY) today announced plans to host a conference call and webcast at 10 a.m. CT, on Tuesday, November... Read more.
Sallie Mae Declares Dividends on Preferred Stock Series B and Common Stock
NEWARK, Del.–(BUSINESS WIRE)–Sallie Mae® (Nasdaq: SLM), formally SLM Corporation, today announced a 2023 fourth-quarter dividend on its Preferred Stock... Read more.
Quanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s Disease
New test elevates the performance standard for blood biomarker tests intended for detecting amyloid pathology in individuals with cognitive impairment BILLERICA,... Read more.
Butterfield Reports Third Quarter 2023 Results
Financial highlights for the third quarter of 2023: Net income of $48.7 million, or $0.99 per share, and core net income1 of $57.0 million, or $1.16 per share Return... Read more.